Portfolio Holdings Detail for ISIN IE00BF4RFH31
Stock Name / FundiShares MSCI World Small Cap UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300PZLRJB7M8H1057
ETF TickerWSML(USD) LSE
ETF TickerWLDS(GBP) LSE
ETF TickerIUSN(EUR) F
ETF TickerIUSN.DE(EUR) CXE
ETF TickerWLDS.LS(GBP) CXE
ETF TickerWSML.LS(USD) CXE
ETF TickerWSML.L(GBP) LSE
ETF TickerWLDS.L(GBP) LSE

Holdings detail for BHVN

Stock NameBiohaven Pharmaceutical Holding Co Ltd
TickerBHVN(USD) NYSE
TYPECommon Stock
CountryUSA
ISINVGG111961055
LEI5299007STZTNN32O9920

Show aggregate BHVN holdings

News associated with BHVN

Biohaven (NYSE:BHVN) and Celularity (NASDAQ:CELU) Head to Head Analysis
Celularity (NASDAQ:CELU – Get Free Report) and Biohaven (NYSE:BHVN – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Volatility and Risk Celularity has a beta of 0.81, […] - 2025-09-17 02:58:44
BTIG Research Forecasts Strong Price Appreciation for Biohaven (NYSE:BHVN) Stock
Biohaven (NYSE:BHVN – Get Free Report) had its price target lifted by equities researchers at BTIG Research from $59.00 to $60.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. BTIG Research’s target price indicates a potential upside of 309.14% from the stock’s previous […] - 2025-08-21 03:06:47
Biohaven (NYSE:BHVN) Price Target Cut to $52.00 by Analysts at Robert W. Baird
Biohaven (NYSE:BHVN – Get Free Report) had its target price reduced by Robert W. Baird from $57.00 to $52.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s price objective would indicate a potential upside of 260.86% from the […] - 2025-08-14 02:52:59
Morgan Stanley Has Lowered Expectations for Biohaven (NYSE:BHVN) Stock Price
Biohaven (NYSE:BHVN – Get Free Report) had its target price lowered by Morgan Stanley from $63.00 to $54.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of 274.74% from the stock’s current price. Other […] - 2025-08-14 02:52:54
Bank of America Cuts Biohaven (NYSE:BHVN) Price Target to $49.00
Biohaven (NYSE:BHVN – Get Free Report) had its price objective reduced by investment analysts at Bank of America from $50.00 to $49.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s price target would suggest a potential upside of 240.04% from the stock’s previous […] - 2025-08-14 02:52:53
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH
Universal Beteiligungs und Servicegesellschaft mbH trimmed its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 21.4% during the first quarter, HoldingsChannel reports. The institutional investor owned 9,463 shares of the company’s stock after selling 2,569 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Biohaven were worth $227,000 at the […] - 2025-08-05 04:38:55
Wednesday's ETF Movers: XBI, OIH
In trading on Wednesday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 1.8% on the day. Components of that ETF showing particular strength include shares of Replimune Group, up about 104.8% and shares of Biohaven, up about 18.9% on the day. And underperfor - 2025-07-30 14:51:58
Wednesday Sector Leaders: Music & Electronics Stores, Biotechnology Stocks
In trading on Wednesday, music & electronics stores shares were relative leaders, up on the day by about 5.7%. Leading the group were shares of Global Industrial, up about 21.2% and shares of Vertiv Holdings up about 2.3% on the day. Also showing relative strength are biot - 2025-07-30 14:51:45
New York State Common Retirement Fund Has $3.85 Million Holdings in Biohaven Ltd. (NYSE:BHVN)
New York State Common Retirement Fund grew its position in Biohaven Ltd. (NYSE:BHVN – Free Report) by 589.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 160,251 shares of the company’s stock after purchasing an additional 137,024 shares during the […] - 2025-07-23 06:58:57
Jennison Associates LLC Has $451,000 Stock Position in Biohaven Ltd. (NYSE:BHVN)
Jennison Associates LLC lowered its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 80.8% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,741 shares of the company’s stock after selling 78,791 shares during the quarter. Jennison Associates LLC’s holdings […] - 2025-07-23 06:21:00
Arizona State Retirement System Acquires 1,810 Shares of Biohaven Ltd. (NYSE:BHVN)
Arizona State Retirement System grew its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 7.9% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,655 shares of the company’s stock after purchasing an additional 1,810 shares during the quarter. Arizona State […] - 2025-07-22 08:54:54
Biohaven Ltd. (NYSE:BHVN) Shares Acquired by Sigma Planning Corp
Sigma Planning Corp increased its holdings in Biohaven Ltd. (NYSE:BHVN – Free Report) by 32.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 10,862 shares of the company’s stock after purchasing an additional 2,661 shares during the quarter. Sigma Planning Corp’s holdings in Biohaven […] - 2025-07-21 05:31:03
Biohaven Ltd. (NYSE:BHVN) Receives $58.46 Average PT from Brokerages
Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have been given a consensus recommendation of “Buy” by the fifteen research firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating […] - 2025-07-18 02:37:05
Analysts Set Biohaven Ltd. (NYSE:BHVN) Price Target at $58.46
Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have been given a consensus rating of “Buy” by the fifteen ratings firms that are presently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, twelve have issued a buy recommendation and two have given a strong buy […] - 2025-06-23 02:14:04
JPMorgan Chase & Co. Lowers Biohaven (NYSE:BHVN) Price Target to $55.00
Biohaven (NYSE:BHVN – Get Free Report) had its price target reduced by stock analysts at JPMorgan Chase & Co. from $68.00 to $55.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside […] - 2025-06-20 02:56:57
Biohaven (NYSE:BHVN) Reaches New 1-Year Low Following Analyst Downgrade
Biohaven Ltd. (NYSE:BHVN – Get Free Report)’s stock price reached a new 52-week low during trading on Wednesday after JPMorgan Chase & Co. lowered their price target on the stock from $68.00 to $55.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Biohaven traded as low as $14.32 and last traded […] - 2025-06-20 02:08:58
California State Teachers Retirement System Purchases 7,005 Shares of Biohaven Ltd. (NYSE:BHVN)
California State Teachers Retirement System lifted its position in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 10.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 74,144 shares of the company’s stock after purchasing an additional 7,005 […] - 2025-06-06 05:06:55
Biohaven Ltd. (NYSE:BHVN) Receives $59.46 Consensus Target Price from Analysts
Biohaven Ltd. (NYSE:BHVN – Get Free Report) has been assigned a consensus rating of “Buy” from the fifteen brokerages that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, twelve have given a buy recommendation and two have issued a strong buy recommendation on the company. […] - 2025-05-29 02:27:28
Two Sigma Advisers LP Trims Stake in Biohaven Ltd. (NYSE:BHVN)
Two Sigma Advisers LP cut its position in Biohaven Ltd. (NYSE:BHVN – Free Report) by 45.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 99,900 shares of the company’s stock after selling 84,300 shares during the quarter. Two Sigma Advisers […] - 2025-05-27 05:24:58
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 13,147 Shares of Biohaven Ltd. (NYSE:BHVN)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 32.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 54,271 shares of the company’s stock after purchasing an additional 13,147 shares […] - 2025-05-22 05:52:58
Nuveen Asset Management LLC Has $34.33 Million Stake in Biohaven Ltd. (NYSE:BHVN)
Nuveen Asset Management LLC raised its position in Biohaven Ltd. (NYSE:BHVN – Free Report) by 55.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 919,235 shares of the company’s stock after purchasing an additional 326,636 shares during the quarter. Nuveen Asset Management LLC […] - 2025-05-21 05:11:02
Biohaven (NYSE:BHVN) Downgraded to Sector Perform Rating by Royal Bank of Canada
Royal Bank of Canada lowered shares of Biohaven (NYSE:BHVN – Free Report) from an outperform rating to a sector perform rating in a report issued on Monday, Marketbeat reports. They currently have $21.00 price objective on the stock, down from their prior price objective of $54.00. Several other equities analysts have also issued reports on […] - 2025-05-20 02:58:54
Ameriprise Financial Inc. Grows Holdings in Biohaven Ltd. (NYSE:BHVN)
Ameriprise Financial Inc. raised its stake in Biohaven Ltd. (NYSE:BHVN – Free Report) by 40.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 508,682 shares of the company’s stock after acquiring an additional 145,331 shares during the period. Ameriprise Financial Inc. owned approximately […] - 2025-05-16 06:02:48
Biohaven (NYSE:BHVN) Stock Price Down 5.3% Following Weak Earnings
Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) traded down 5.3% during trading on Tuesday following a dissappointing earnings announcement. The stock traded as low as $19.33 and last traded at $19.48. 486,099 shares traded hands during mid-day trading, a decline of 58% from the average session volume of 1,169,407 shares. The stock had […] - 2025-05-15 02:40:44
Biohaven Ltd. (NYSE:BHVN) Receives Average Recommendation of “Buy” from Analysts
Shares of Biohaven Ltd. (NYSE:BHVN – Get Free Report) have been given a consensus recommendation of “Buy” by the fifteen brokerages that are covering the company, Marketbeat Ratings reports. Fourteen equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 […] - 2025-05-01 02:12:47
Robert W. Baird Has Lowered Expectations for Biohaven (NYSE:BHVN) Stock Price
Biohaven (NYSE:BHVN – Get Free Report) had its price objective reduced by investment analysts at Robert W. Baird from $60.00 to $57.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird’s target price suggests a potential upside of 160.39% from the […] - 2025-04-30 03:00:48
Biohaven Sees Unusually Large Options Volume (NYSE:BHVN)
Biohaven Ltd. (NYSE:BHVN – Get Free Report) saw unusually large options trading on Tuesday. Traders purchased 7,638 call options on the stock. This represents an increase of 588% compared to the typical daily volume of 1,110 call options. Biohaven Trading Up 2.7 % Shares of NYSE:BHVN opened at $21.10 on Wednesday. The company has a […] - 2025-04-23 02:28:49
Barclays PLC Has $14.67 Million Stock Position in Biohaven Ltd. (NYSE:BHVN)
Barclays PLC boosted its stake in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 46.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 392,727 shares of the company’s stock after buying an additional 124,650 shares during the period. Barclays PLC […] - 2025-04-21 06:12:48
Summit Investment Advisors Inc. Has $336,000 Stake in Biohaven Ltd. (NYSE:BHVN)
Summit Investment Advisors Inc. increased its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 18.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,985 shares of the company’s stock after acquiring an additional 1,378 shares during the quarter. Summit Investment […] - 2025-04-21 04:56:55
Federated Hermes Inc. Trims Stock Holdings in Biohaven Ltd. (NYSE:BHVN)
Federated Hermes Inc. reduced its holdings in shares of Biohaven Ltd. (NYSE:BHVN – Free Report) by 41.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,753 shares of the company’s stock after selling 8,869 shares during the quarter. Federated Hermes Inc.’s holdings […] - 2025-04-18 05:26:52

iShares MSCI World Small Cap UCITS ETF USD (Acc) BHVN holdings

DateNumber of BHVN Shares HeldBase Market Value of BHVN SharesLocal Market Value of BHVN SharesChange in BHVN Shares HeldChange in BHVN Base ValueCurrent Price per BHVN Share HeldPrevious Price per BHVN Share Held
2025-10-15 (Wednesday)60,291USD 1,046,652USD 1,046,652
2025-10-10 (Friday)59,913USD 946,625USD 946,625
2025-10-08 (Wednesday)59,913USD 919,065USD 919,065
2025-10-07 (Tuesday)59,913BHVN holding increased by 252USD 899,893BHVN holding decreased by -47524USD 899,893252USD -47,524 USD 15.02 USD 15.88
2025-10-06 (Monday)59,661USD 947,417BHVN holding increased by 4177USD 947,4170USD 4,177 USD 15.88 USD 15.81
2025-10-03 (Friday)59,661USD 943,240BHVN holding increased by 17898USD 943,2400USD 17,898 USD 15.81 USD 15.51
2025-10-02 (Thursday)59,661USD 925,342BHVN holding increased by 41166USD 925,3420USD 41,166 USD 15.51 USD 14.82
2025-10-01 (Wednesday)59,661USD 884,176BHVN holding decreased by -11336USD 884,1760USD -11,336 USD 14.82 USD 15.01
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BHVN by Blackrock for IE00BF4RFH31

Show aggregate share trades of BHVN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-07BUY252 15.020* 27.67
2025-09-08SELL-500 14.490* 28.43 Profit of 14,216 on sale
2025-08-15BUY250 15.710* 28.51
2025-08-07BUY744 15.230* 28.68
2025-07-29BUY250 12.830* 29.20
2025-07-14BUY504 14.190* 29.91
2025-06-30BUY504 14.110* 30.66
2025-06-25BUY750 14.330* 31.00
2025-06-20SELL-127 14.460* 31.36 Profit of 3,982 on sale
2025-06-12SELL-1,008 15.590* 32.10 Profit of 32,353 on sale
2025-06-02BUY381 15.680* 33.11
2025-05-28BUY252 15.060* 33.56
2025-05-14BUY124 19.660* 35.11
2025-05-13BUY248 19.510* 35.25
2025-05-07BUY372 19.020* 35.82
2025-04-28BUY123 21.740* 36.80
2025-04-16BUY1,625 18.680* 38.20
2025-04-14BUY248 18.510* 38.64
2025-04-08SELL-248 16.540* 39.62 Profit of 9,826 on sale
2025-04-04SELL-248 18.590* 40.13 Profit of 9,952 on sale
2025-03-28BUY1,230 27.650* 40.91
2025-03-12SELL-246 29.410* 43.00 Profit of 10,577 on sale
2025-03-04SELL-244 31.370* 44.04 Profit of 10,746 on sale
2025-02-26SELL-488 37.180* 44.60 Profit of 21,767 on sale
2025-02-13BUY6,180 41.790* 45.59
2025-02-12BUY436 42.120* 45.67
2025-01-27BUY108 39.930* 47.84
2025-01-23BUY108 40.710* 48.29
2024-12-09BUY3,888 43.250* 48.86
2024-12-04BUY216 46.060* 49.29
2024-12-03BUY324 43.680* 49.49
2024-11-19BUY648 46.300* 51.43
2024-11-18BUY216 45.410* 51.78
2024-11-12BUY428 50.360* 51.87
2024-11-11BUY107 52.430* 51.83
2024-11-07BUY535 53.090* 51.61
2024-10-23BUY214 52.750* 52.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BHVN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19294,223495720,12640.9%
2025-09-18387,1781,884882,40743.9%
2025-09-17640,12219,5491,241,32651.6%
2025-09-16269,190112555,24148.5%
2025-09-15331,5050615,07153.9%
2025-09-12308,6390688,83644.8%
2025-09-11273,8720648,09942.3%
2025-09-10311,9274,850757,94341.2%
2025-09-09294,3983,630547,34553.8%
2025-09-08823,96723,7841,735,90547.5%
2025-09-05630,6979001,259,54150.1%
2025-09-04306,7460484,03963.4%
2025-09-03593,904141,189,41549.9%
2025-09-02214,9710513,95341.8%
2025-08-29190,751139310,64061.4%
2025-08-28192,584255327,20558.9%
2025-08-27243,821999526,63046.3%
2025-08-26318,763331591,34253.9%
2025-08-25453,9380855,05053.1%
2025-08-22949,5252381,899,40250.0%
2025-08-21198,530250443,36844.8%
2025-08-20223,489679389,59057.4%
2025-08-19777,80401,094,20771.1%
2025-08-18369,7760724,62451.0%
2025-08-15499,4301,9611,263,18739.5%
2025-08-14194,4480381,46751.0%
2025-08-13472,2270785,82360.1%
2025-08-12553,66725,530842,78065.7%
2025-08-11721,94136,5111,144,40663.1%
2025-08-08615,3869972,65163.3%
2025-08-07268,51214450,80759.6%
2025-08-06390,3900553,80570.5%
2025-08-05382,76842506,95375.5%
2025-08-04232,1361386,77660.0%
2025-08-01422,6300761,79955.5%
2025-07-31429,93301,033,68541.6%
2025-07-301,269,0321,7883,226,41339.3%
2025-07-29246,682165700,97335.2%
2025-07-28208,2893,750747,63727.9%
2025-07-25160,04781494,49532.4%
2025-07-24104,7880405,90425.8%
2025-07-23130,2550588,41422.1%
2025-07-22156,194500489,46831.9%
2025-07-21202,5390478,56542.3%
2025-07-18235,0050643,07136.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.